Skip to main content

Replimune Group, Inc.

REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737953

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Replimune Group, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of REPL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders140141+1
Shares53.8M54.6M+788.1K (+1.5%)
Value$949.0M$1.27B+$318.3M (+33.5%)

New holders (20)

Institutions that held Replimune Group, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to REPL in Q2 2023
InstitutionSharesValue% of portfolio
Lord, Abbett & Co. LLC1,038,506$24.1M0.08%
Sofinnova Investments, Inc.348,889$8.10M0.53%
HRT Financial LP116,469$2.70M0.03%
Walleye Capital LLC50,663$1.18M0.02%
Captrust Financial Advisors44,377$1.03M0.00%
Simplex Trading, LLC41,332$959.0K0.04%
Caption Management, LLC32,968$765.5K0.13%
Skandinaviska Enskilda Banken AB (publ)31,800$738.0K0.00%
Ergoteles LLC18,170$421.9K0.02%
Engineers Gate Manager LP14,889$345.7K0.01%
HSBC Holdings PLC13,574$321.3K0.00%
Ghost Tree Capital, LLC10,865$252.3K0.09%
Group One Trading, L.P.9,700$225.2K0.01%
ProShare Advisors LLC9,037$209.8K0.00%
Exchange Traded Concepts, LLC5,898$137.0K0.00%
Oliver Lagore Vanvalin Investment Group100$2.32K0.00%
Lindbrook Capital, LLC77$1.79K0.00%
The PNC Financial Services Group, Inc.65$1.51K0.00%
Quadrant Capital Group LLC44$1.02K0.00%
Versant Capital Management, Inc28$6500.00%

Sold out (19)

Institutions that held Replimune Group, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.